WallStreetZenWallStreetZen

AnalystsMichael Schmidt
Michael Schmidt's Stock Forecasts

Analyst Ranking
Top 17%
#765 out of 4476 analysts
Average Return
+12.87%
Win Rate
54%21 out of 39
Risk vs Reward
Poor
Good

Michael Schmidt's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Immunomedics IncIMMU
+235.60%$26.18$87.86
2020-04-23 -
2020-10-22
Strong Buy
Mirati Therapeutics IncMRTX
+182.05%$13.20$37.23
2017-11-14 -
2018-11-14
Buy
Forty Seven IncFTSV
+165.60%$35.96$95.51
2019-12-11 -
2020-04-06
Strong Buy
Mirati Therapeutics IncMRTX
+87.42%$31.32$58.70
2023-07-24 -
2024-01-22
Strong Buy
Zentalis Pharmaceuticals IncZNTL
+67.39%$35.57$59.54
2020-04-28 -
2021-04-28
Strong Buy

Michael Schmidt's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Immunogen IncIMGN
1Hold$31.00-0.74%Downgrades
3 months ago
Xencor IncXNCR
2Strong Buy$34.00+38.95%Maintains
4 months ago
Exelixis IncEXEL
3Strong Buy$30.00+39.34%Reiterates
4 months ago
Syndax Pharmaceuticals IncSNDX
2Strong Buy$42.00+81.58%Maintains
7 months ago
Mirati Therapeutics IncMRTX
4Strong Buy$60.00+2.21%Maintains
7 months ago
Adicet Bio IncACET
3Hold$20.00+709.72%Downgrades
8 months ago
Mersana Therapeutics IncMRSN
1Strong Buy$14.00+269.39%Initiates Coverage On
8 months ago
Blueprint Medicines CorpBPMC
1Strong Buy$82.00-8.37%Maintains
9 months ago
Immunocore Holdings PLCIMCR
1Strong Buy$85.00+21.67%Initiates Coverage On
a year ago
Oric Pharmaceuticals IncORIC
2Hold$15.00+36.12%Downgrades
a year ago
Seagen IncSGEN
3Strong Buy$170.00-25.68%Reiterates
a year ago
Beigene LtdBGNE
3Strong Buy$350.00+125.66%Reiterates
a year ago
Deciphera Pharmaceuticals IncDCPH
1Strong Buy$22.00N/AUpgrades
a year ago
Adaptimmune Therapeutics PLCADAP
1Strong Buy$5.00N/AUpgrades
a year ago
Neurogene IncNGNE
2HoldN/AN/ADowngrades
a year ago
Zentalis Pharmaceuticals IncZNTL
2Strong Buy$28.00N/AMaintains
a year ago
Rubius Therapeutics IncRUBY
2HoldN/AN/ADowngrades
a year ago
Incyte CorpINCY
2HoldN/AN/ADowngrades
2 years ago
Immuneering CorpIMRX
1Strong Buy$42.00N/AInitiates Coverage On
3 years ago
Erasca IncERAS
1Strong Buy$25.00N/AInitiates Coverage On
3 years ago
Monte Rosa Therapeutics IncGLUE
1Strong Buy$30.00N/AInitiates Coverage On
3 years ago
Rain Oncology IncRAIN
1Strong Buy$26.00N/AInitiates Coverage On
3 years ago
Cellectis SaCLLS
1HoldN/AN/ADowngrades
3 years ago
Bolt Biotherapeutics IncBOLT
1Strong Buy$42.00N/AInitiates Coverage On
3 years ago
Immunomedics IncIMMU
1Strong Buy$39.00N/AMaintains
4 years ago
Revolution Medicines IncRVMD
1Strong Buy$50.00N/AInitiates Coverage On
4 years ago
Spectrum Pharmaceuticals IncSPPI
1HoldN/AN/ADowngrades
4 years ago
Forty Seven IncFTSV
1Strong Buy$48.00N/AMaintains
4 years ago
Bluebird Bio IncBLUE
3HoldN/AN/ADowngrades
5 years ago
Agios Pharmaceuticals IncAGIO
3Buy$80.00N/AUpgrades
5 years ago
Clovis Oncology IncCLVSQ
2Hold$30.00N/AInitiates Coverage On
5 years ago
Five Prime Therapeutics IncFPRX
1Buy$24.00N/AReinstates
5 years ago
Array Technologies IncARRY
1Buy$20.00N/AMaintains
6 years ago
Juno Therapeutics IncJUNO
2Hold$87.00N/ADowngrades
6 years ago
Arbutus Biopharma CorpABUS
1Hold$5.50N/AMaintains
6 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.